Holen Sie sich die Stockscreener-App
1.27
2.85%
0.04
Schlusskurs vom Vortag:
$1.23
Offen:
$1.32
24-Stunden-Volumen:
3.29M
Relative Volume:
0.86
Marktkapitalisierung:
$280.68M
Einnahmen:
$95,000
Nettoeinkommen (Verlust:
$-327.27M
KGV:
-0.5991
EPS:
-2.12
Netto-Cashflow:
$-239.25M
1W Leistung:
-8.33%
1M Leistung:
+11.95%
6M Leistung:
-12.76%
1J Leistung:
-52.26%
1-Tages-Spanne:
$1.20
$1.33
1-Wochen-Bereich:
$1.20
$1.53
52-Wochen-Spanne:
$0.8621
$3.78
Allogene Therapeutics Inc Stock (ALLO) Company Profile
Firmenname
Allogene Therapeutics Inc
Sektor
Branche
Telefon
(650) 457-2700
Adresse
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALLO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLO
Allogene Therapeutics Inc
|
1.265 | 272.91M | 95,000 | -327.27M | -239.25M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.12 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-05-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-08-08 | Fortgesetzt | Oppenheimer | Outperform |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-05 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-01-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-12-08 | Eingeleitet | Citigroup | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-21 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-01-06 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-12-12 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-08-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-15 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-03 | Eingeleitet | Robert W. Baird | Neutral |
| 2022-02-28 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-20 | Eingeleitet | Cowen | Outperform |
| 2021-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2021-10-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-06-21 | Fortgesetzt | Jefferies | Buy |
| 2021-05-20 | Hochstufung | Truist | Hold → Buy |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-26 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-10 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-11-24 | Eingeleitet | BofA Securities | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-06-01 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-05-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-19 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-15 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-14 | Herabstufung | SunTrust | Buy → Hold |
| 2020-04-13 | Eingeleitet | SunTrust | Buy |
| 2020-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-05 | Eingeleitet | Stifel | Hold |
| 2020-02-24 | Eingeleitet | Berenberg | Hold |
| 2019-12-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-11-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-09 | Eingeleitet | BTIG Research | Buy |
| 2019-06-05 | Eingeleitet | ROTH Capital | Neutral |
| 2019-05-31 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-23 | Eingeleitet | Stifel | Hold |
| 2019-03-29 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Allogene Therapeutics Inc Aktie (ALLO) Neueste Nachrichten
What to do if you’re stuck in Allogene Therapeutics Inc.2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Chart based analysis of Allogene Therapeutics Inc. trendsTrade Ideas & Verified Stock Trade Ideas - newser.com
What’s the recovery path for long term holders of Allogene Therapeutics Inc.July 2025 Review & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-10 09:33:16 - newser.com
Applying sector rotation models to Allogene Therapeutics Inc.July 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Is Allogene Therapeutics Inc. stock poised for growth2025 Price Targets & Technical Pattern Based Buy Signals - newser.com
Allogene, Pliant down as J.P. Morgan cuts to Underweight on uncertain outlook - Seeking Alpha
JP Morgan Downgrades Allogene Therapeutics (ALLO) to Underweight - GuruFocus
JPMorgan Downgrades Allogene Therapeutics to Underweight From Neutral - MarketScreener
What technical models suggest about Allogene Therapeutics Inc.’s comebackWeekly Profit Recap & Weekly Breakout Watchlists - newser.com
Allogene Therapeutics Inc. stock volume spike explainedMarket Growth Report & Real-Time Volume Analysis - newser.com
Allogene Therapeutics' (ALLO) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
What analysts say about Allogene Therapeutics Inc stockFundamental Stock Analysis & Free Triple Digit Wealth Increase - earlytimes.in
Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus - MSN
Measuring Allogene Therapeutics Inc.’s beta against major indicesCEO Change & Consistent Profit Trade Alerts - newser.com
What does recent volatility data suggest for Allogene Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Guides - newser.com
What indicators show strength in Allogene Therapeutics Inc.Weekly Profit Report & Fast Moving Market Watchlists - newser.com
Market reaction to Allogene Therapeutics Inc.’s recent newsMarket Weekly Review & AI Driven Price Predictions - newser.com
Published on: 2025-10-05 03:06:55 - newser.com
Allogene Therapeutics (NASDAQ:ALLO) Rating Increased to Hold at Wall Street Zen - MarketBeat
Allogene Therapeutics at Citi’s SMID Call Series: Strategic Insights By Investing.com - Investing.com Canada
Published on: 2025-10-03 05:33:11 - newser.com
Applying big data sentiment scoring on Allogene Therapeutics Inc.Short Setup & Capital Efficient Trade Techniques - newser.com
Published on: 2025-10-02 20:30:24 - newser.com
Published on: 2025-10-01 08:38:29 - newser.com
Analyzing net buyer seller activity in Allogene Therapeutics Inc.July 2025 Review & Daily Technical Forecast Reports - newser.com
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Published on: 2025-09-29 14:28:46 - newser.com
Published on: 2025-09-29 11:38:34 - newser.com
Published on: 2025-09-29 07:57:40 - newser.com
Will Allogene Therapeutics Inc. stock beat EPS estimatesJuly 2025 Selloffs & Smart Allocation Stock Reports - The British Mountaineering Council
344,880 Shares in Allogene Therapeutics, Inc. $ALLO Purchased by Kingstone Capital Partners Texas LLC - MarketBeat
Real time scanner hits for Allogene Therapeutics Inc. explained2025 Technical Overview & Weekly High Return Forecasts - newser.com
Profit Recap: Can Allogene Therapeutics Inc. be the next market leaderPortfolio Performance Summary & AI Forecasted Stock Moves - khodrobank.com
Will Allogene Therapeutics Inc stock hit new highs in YEAR2025 Fundamental Recap & Reliable Breakout Forecasts - khodrobank.com
Custom watchlist performance reports with Allogene Therapeutics Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Update Report: Will Allogene Therapeutics Inc benefit from geopolitical trends2025 Market Sentiment & AI Driven Price Predictions - khodrobank.com
Allogene Therapeutics (NASDAQ:ALLO) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Using fundamentals and technicals on Allogene Therapeutics Inc.Portfolio Profit Report & Weekly Top Performers Watchlists - newser.com
Aug PostEarnings: Can Allogene Therapeutics Inc reach resistance levels soonJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک
History Review: Will Allogene Therapeutics Inc benefit from geopolitical trendsDip Buying & Weekly Momentum Stock Picks - خودرو بانک
Aug Reactions: What are the risks of holding Allogene Therapeutics Inc2025 Volume Leaders & Weekly Momentum Stock Picks - خودرو بانک
Bearish Setup: Will Allogene Therapeutics Inc stock hit new highs in YEAR2025 Price Momentum & Daily Oversold Bounce Ideas - خودرو بانک
Gainers Report: Will Allogene Therapeutics Inc outperform the market in YEAR2025 Macro Impact & Verified Entry Point Detection - خودرو بانک
Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):